This site is intended for healthcare professionals only
LoginRegister

Psychiatry Dialogues

Cariprazine Shows High Tolerability and Completion Rates in Major Depressive Disorder Patients

Cariprazine Shows High Tolerability and Completion Rates in Major Depressive Disorder Patients

Cariprazine, approved by the FDA as an adjunctive treatment for MDD, has demonstrated positive outcomes in various trials. The analysis focused on its...
View All

Latest News and Guidelines

Common antidepressants SSRI and SNRI found safe for most stroke survivors

Common antidepressants SSRI and SNRI found safe for most stroke survivors

Heavy cannabis use may increase risk of developing anxiety disorder, study suggests

Heavy cannabis use may increase risk of developing anxiety disorder, study suggests

Patients of Mild Covid-19 with anxiety or depression more likely to suffer from insomnia

Patients of Mild Covid-19 with anxiety or depression more likely to suffer from insomnia

Major study reveals brain changes due to childhood trauma

Major study reveals brain changes due to childhood trauma

Blood pressure drug to reduce anxiety for people with autism finds study

Blood pressure drug to reduce anxiety for people with autism finds study

Vitamin D supplementation fails to reduce multiple sclerosis activity after clinically isolated syndrome: Study

Vitamin D supplementation fails to reduce multiple sclerosis activity after clinically isolated...

View All
X